European Commission Fines Teva & Cephalon for Delaying Entry of Generic Modafinil
The commission investigation has found that for several years, this “pay-for-delay” agreement eliminated Teva as a competitor and allowed Cephalon to continue charging high prices even if the main modafinil patent had long expired.